Table 3. Side effects and compliance.
Adverse events | BT group (N=130) | SQ group (N= 132) | CT group (N= 131) | p |
Diarrhea | 7% (9) | 12.9% (17) | 23.7% (31) | 0.001 |
Abdominal pain | 3.1% (4) | 10.6% (14) | 14.0% (19) | 0.005 |
Metallic taste | 2.3% (3) | 4.5% (6) | 19.8% (26) | 0.0001 |
Nausea/Vomiting | 0.8% (1) | 3.8% (5) | 10% (13) | 0.001 |
Headache | 3.1% (4) | 3.8% (5) | 8.4% (11) | 0.11 |
Skin eruption | 1.5% (2) | 0.8% (1) | 0.8% (1) | 0.7 |
Asthenia | 3.1% (4) | 3.8% (5) | 4.6% (6) | 0.8 |
Compliance^ | 93.8% | 98.5% | 95.9% | 0.16 |